Given that enhanced expressions of ACE2 in ileal and colonic tissue were observed in IBD (including CD and UC) (Garg et al., 2020), it is reasonable to draw a possible conclusion that IBD patients may suffer a higher risk of Long COVID mediated by ACE2. This evidence concerns the gene ACE2 and inflammatory bowel disease.